Gracell taken over in the US by AstraZeneca for $1.2b usd.
these things can happen quick once the data rolls in.
CHM have the team and look to have the treatments to achieve this or more.
deals are happening and in the Car-t space. I’m looking forward to an exciting 2024 for CHM.
a deal for CHM1101 is the first cab off the rank but who knows the exact timing . My guess is Merck will be interested if phase1b results look as good as the phase 1a.
can’t wait for the final phase 1a data read out.
just remember the results can be impressive and the market may not notice but BP will know what’s up
watched Gracell make great announcements and sp didn’t respond.
once they presented at ASCO sp started to rise and bang takeover
CHM Price at posting:
2.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)